Bluejay Diagnostics, Inc. Purchase Obligation, to be Paid, Year One
Bluejay Diagnostics, Inc. (BJDX) had Purchase Obligation, to be Paid, Year One of $1.00 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Notes › Commitment and Contingencies
us-gaap:PurchaseObligationDueInNextTwelveMonths · last filed 2022-11-09
- 2022-09-30: Purchase Obligation, to be Paid, Year One $1.00M.
- 2022-06-30: Purchase Obligation, to be Paid, Year One $600.00K.
- 2022-03-31: Purchase Obligation, to be Paid, Year One $1.00M.
- 2021-12-31: Purchase Obligation, to be Paid, Year One $1.50M.
| Period end | Purchase Obligation, to be Paid, Year One |
|---|---|
| 2022-09-30 | $1.00M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $600.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.00M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.50M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |